On January 29th, the common shares of Abacus Health Products Inc. (CSE:ABCS) were approved for listing on the Canadian Securities Exchange. Today, shares of Abacus Health Products began trading, and they’re already up big.
Abacus Health Products is engaged in the development and commercialization of over-the-counter topical pain-relieving products infused with cannabidiol, a.k.a. CBD. As the health benefits of CBD become more clear within the medical community, it comes as no surprise that companies like Abacus Health Products are looking to take their piece of the market.
All products commercialized by the company are registered with the U.S. Food and Drug Administration and utilize FDA-approved analgesic ingredients. The products of the company are aimed at the rapidly growing market for topical pain relief and are based on proprietary patent-pending technologies developed by the company.
Abacus Health Products Stock Details
|Issuer/Émetteur:||Abacus Health Products Inc.|
|Security Type/Titre:||Subordinate Voting Shares/Actions à droit de vote subalterne|
|Number of securities issued and outstanding/ Titres émis et en circulation:||5 564 331|
|Number of Securities reserved for issuance/ Titres réservés pour émission:||14 912 152|
|CSE Sector/Catégorie:||Life Sciences/Sciences biologiques|
|Trading Currency/Monnaie de négociation:||CDN$/$CDN|
|Trading Date/Date de negociation:||le 30 janvier/January 2019|
|Other Exchanges/Autres marches:||N/A|
|Fiscal Year end /Clôture de l’exercice financier:||Le 31 décembre/December|
|Transfer Agent/Agent des transferts:||Odyssey Trust Company|
With a last traded price of $9.49 CAD per share of ABCS, the company is certainly attracting investor interest. Be sure to subscribe to updates here so you never miss an important update.
Get Real-Time Updates from MJobserver.com